Department of Vascular Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA.
J Vasc Surg. 2013 Sep;58(3):573-81. doi: 10.1016/j.jvs.2013.02.239. Epub 2013 Jul 1.
While a positive family history (FH) is a known risk factor for developing an aneurysm, its association with the extent of disease has not been established. We evaluated the influence of a FH of aortic disease with respect to the pattern and distribution of aortic aneurysms in a given patient.
From November 1999 to November 2011, 1263 patients were enrolled in physician-sponsored endovascular device trials to treat aortic aneurysms. Of the 555 patients who were alive and returning for follow-up, we obtained 426 (77%) family histories. Three-dimensional imaging studies were used to identify the presence of aneurysms; 36% (155/426) of patients had a FH of aortic aneurysms and 5% (21/155) had isolated intracranial aneurysms. A logistic regression model was used to compare aortic morphology between patients with a positive or negative FH for aneurysms. Patients with a positive FH of aortic aneurysms were younger at their initial aneurysm (63 vs 70 years; P < .0001), more frequently had proximal aortic involvement (root: odds ratio [OR], 5.4; P < .0001; ascending: OR, 2.9; P < .001; thoracic: OR, 2.2; P = .01) with over 50% of FH patients ultimately developing suprarenal aortic involvement (P = .0001) and had a greater incidence of bilateral iliac artery aneurysm (OR, 1.8; P = .03).
FH is an important tool that provides insight into the expected behavior of the untreated aorta and has significant implications for the development of treatment strategies. These findings should be used to guide patient's management with regard to treatment, follow-up paradigms, genetic testing, and screening of other family members.
虽然阳性家族史(FH)是发生动脉瘤的已知危险因素,但它与疾病程度的关系尚未确定。我们评估了 FH 对特定患者主动脉瘤模式和分布的影响。
1999 年 11 月至 2011 年 11 月,1263 名患者参加了医生赞助的血管内设备试验,以治疗主动脉瘤。在 555 名存活并返回随访的患者中,我们获得了 426 名(77%)家族史。使用三维成像研究来确定动脉瘤的存在;36%(155/426)的患者有 FH 主动脉瘤,5%(21/155)有孤立性颅内动脉瘤。使用逻辑回归模型比较 FH 阳性或阴性患者的主动脉形态。FH 阳性主动脉瘤患者的初始动脉瘤年龄更轻(63 岁比 70 岁;P <.0001),更常发生近端主动脉受累(根部:优势比[OR],5.4;P <.0001;升主动脉:OR,2.9;P <.001;胸主动脉:OR,2.2;P =.01),超过 50%的 FH 患者最终发生肾上主动脉受累(P =.0001),双侧髂动脉瘤的发生率更高(OR,1.8;P =.03)。
FH 是一个重要的工具,可以深入了解未经治疗的主动脉的预期行为,并对治疗策略的制定有重要意义。这些发现应用于指导患者的管理,包括治疗、随访模式、基因测试和其他家庭成员的筛查。